Suggestions
Michal Wlodarski, PhD
Co-Founder & COO at Solvemed | Adj. Professor at IE University Madrid | Hon. Lecturer at University College London
Michal Wlodarski, PhD is a multifaceted professional with extensive experience in the healthcare and technology sectors. Here's an overview of his key roles and accomplishments:
Professional Positions
Current Roles::
- Co-Founder & Chief Operating Officer at Solvemed Group, a VC-backed Neuroscience AI company focused on redefining neurology care and drug development1
- Adjunct Professor at IE University in Madrid, where he shares his experience and teaches relevant courses12
- Honorary Lecturer & Mentor at UCL Institute of Ophthalmology1
- Mentor & External Assessor at UCL School of Management, supervising and assessing MSc thesis projects on health tech innovation1
Previous Experience::
- Principal (Life Sciences) at Cambridge Innovation Consulting Ltd1
- Clinical Pharmacist Pre-Reg at Basildon & Thurrock University Hospitals NHS Foundation Trust1
- Industrial Pharmacist Pre-Reg at GlaxoSmithKline1
- Research Assistant in Public Health Policy at University College London1
Education
- PhD in Biological Sciences from the University of Cambridge (2014-2017)1
- Master of Research (MRes) from the University of Cambridge (2013-2014)1
- Bachelor of Pharmacy (MPharm) with first-class honours from UCL (2012)1
Expertise and Focus
Dr. Wlodarski's work at Solvemed Group involves leveraging proprietary machine learning technology to develop digital biomarkers for neurological drugs and establish affordable clinical examination and remote monitoring tools.1 His expertise spans across neuroscience, AI in healthcare, and pharmaceutical development.
Additional Certifications
Dr. Wlodarski has pursued various certifications to enhance his skills, including programs from the BioIndustry Association, NVIDIA, P4 Precision Medicine Accelerator, Panacea Innovation, and Plug and Play Tech Center.1
Dr. Michal Wlodarski is based in Cambridge, UK, and continues to be active in both academic and entrepreneurial pursuits in the field of healthcare technology and innovation.34